Biogen, Inc. (BIIB)
$330.67
3.94 (1.21%)
BIIB Stock Quote Delayed 30 Minutes
Biogen: Does Aduhelm Make it the Next Dendreon?
Aduhelm was approved by the FDA, priced at $56,000/year, but it isn't a cure for Alzheimer's.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
49.28B
PE Ratio
26.54
EPS
12.46
Volume (Avg. Vol.)
152,026
Day's Range
326.26 - 331.89
52-Week Range
223.25 - 468.35
Dividend & Yield
N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen, Inc. News
New Alzheimer’s Treatment Is A Huge Catalyst for Biogen
BIIB stock was boosted when its Alzheimer's drug was approved. The company's strong financials can sustain the stock's growth.
BIIB Stock: 9 Things to Know About Biogen’s Alzheimer Drug Approval Controversy
Biogen (BIIB) stock is dipping lower today on the additional controversy surrounding the approval of its Alzheimer’s drug, Aduhelm.
Biogen Gets an Unearned Rip on an Unproven Drug
Critics charge the FDA has been compromised and approved Biogen's Alzheimer's drug before it is proven to work.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? Investors scrutinized updates to the Colonial Pipeline saga and bet on meme stocks.
4 Top Stock Trades for Tuesday: Bitcoin, BIIB, YETI, COUP
Bitcoin, Biogen, Yeti and Coupa were our top stock trades for Tuesday. Let's take a look at the charts and see how these names are looking.
BIIB Stock Alert: The Huge FDA News That Has Biogen Investors Smiling
Shares of BIIB stock were up to start the day on Monday after the FDA approved the firm's experimental drug to fight Alzheimer’s disease.
14 AI Stocks to Stay Away From
Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.
4 Top Stock Trades for Thursday: BIIB, PTON, GM, WEN
Biogen, Peloton, General Motors and Wendy's were our top stock trades for Thursday. Now, let's look at the charts to see what's going on.
Biogen Earnings: BIIB Stock Jumps 1% Higher on Q2 Beats
Biogen earnings on Wednesday have BIIB stock higher after the company crushed Wall Street's expectations for EPS and revenue for the quarter.
Potential Alzheimer’s Drug Not Enough to Excite Biogen Stock Investors
Biogen opened higher by around 10% on news of its Alzheimer's drug. By the end of day, BIIB stock gave up a bulk of its gains. What gives?
4 Top Stock Trades for Thursday: TWTR, NIO, BIIB, SNAP
Snap, Nio, Biogen and Twitter were our top stock trades for Thursday. That said, let's see how the charts are setting up after some big moves.
Biogen News: BIIB Stock Battered 7% by MS Drug Patent Ruling
Biogen (BIIB) news for Thursday concerning a lost court ruling surrounding its multiple sclerosis drug has BIIB stock taking a beating.
As Biogen Stock Struggles, Look Elsewhere for Biotech Exposure
Biogen has solid and consistent revenue, profit and cash flow. But Biogen stock has a low valuation because it has no growth.
